Physician profile
Julia Wicks
NPI 1750175576
$429.35
in general payments reported to CMS, 2019-2025
13 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $66.51 | 2025 | Symbravo |
| Lundbeck LLC | $58.35 | 2025 | Rexulti |
| Exact Sciences Corporation | $34.40 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $34.16 | 2025 | Rexulti |
| Abiomed | $34.08 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $30.06 | 2025 | Airsupra |
| Janssen Pharmaceuticals, INC | $29.63 | 2025 | Spravato |
| Teleflex LLC | $29.01 | 2025 | Urolift |
| Vivus LLC | $27.59 | 2025 | Pancreaze |
| Abbott Laboratories | $26.26 | 2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $24.04 | 2025 | Wegovy |
| Abbvie INC. | $21.77 | 2025 | |
| Xeris Pharmaceuticals, INC. | $13.49 | 2025 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Wicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.